about
IL-4/10 prevents stress vulnerability following imipramine discontinuation.Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine.Interplay between Depressive-Like Behavior and the Immune System in an Animal Model of Prenatal Dexamethasone AdministrationProlonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.Probiotic 'glow of health': it's more than skin deep.Association between Interlukin-6 (IL-6), Interlukin-10 (IL-10) and depression in patients undergoing Hematopoietic stem cell transplantation.Depressive-like behavior, its sensitization, social buffering, and altered cytokine responses in rhesus macaques moved from outdoor social groups to indoor housing.CREB-mediated alterations in the amygdala transcriptome: coordinated regulation of immune response genes following cocaine.Contributions of animal models to the study of mood disorders.Association between depression and inflammatory/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: a review of literature.Potential antianxiety activity of Fumaria indica: A preclinical study.Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trialStudy on anti-inflammatory and immunomodulatory effects of clomipramine in carrageenan- and lipopolysaccharide-induced rat models of inflammation.Peripheral Immune Alterations in Major Depression: The Role of Subtypes and Pathogenetic Characteristics.Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study.Premature mammary gland involution with repeated corticosterone injection in interleukin 10-deficient mice.Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus.Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative PathwaysInvolvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression
P2860
Q30671322-2686B173-F7E5-4F75-A553-9B8F9970F862Q30855337-CC553A47-3B27-4EEA-B509-66BA89C0ABCCQ34565661-4B73B3E7-EAEE-4A25-8108-1F194A45E630Q34631833-17108121-2437-41E2-9E70-D5F17FC11F58Q35163037-6DFDAB5B-E033-4B4A-AE7C-DBCB78EBF15BQ35540027-254660CC-D5C2-41A1-82D5-ABC7C1C94326Q37184276-E07FAF68-B186-4950-8B87-4738442D9D66Q37673963-F7C035BF-BF8D-4BC7-9619-4487710F5E4FQ38165755-71F3D660-BF9E-48A5-BD15-3571AA31173FQ38231472-A93A2F52-7D60-42F4-833C-AB39C76C4FD5Q40503029-83F22940-0CA3-466F-9F91-2FB41E1FC5D0Q41173157-1A32799D-7429-4997-B7B5-B24C323386FBQ41938917-50B2F6BA-3C8A-42EC-A086-7B144E7431B6Q47096939-37B00556-CBC0-41A9-8442-1A7E0C216A10Q48379121-13A44837-9FB3-48C3-ABE8-22C4D76B670BQ51598667-9C3922EB-2CB0-4A0D-A5AF-0E2B2C05C5BBQ53427550-9A9BEB69-F12E-47A4-9C4C-4EFD08C1404DQ56005401-E2503F49-7641-41B3-9933-540B5919BB2FQ58769612-19B49555-C223-43A5-A27F-06CC2A28B3D9
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Interleukin-10: a key cytokine in depression?
@en
Interleukin-10: a key cytokine in depression?
@nl
type
label
Interleukin-10: a key cytokine in depression?
@en
Interleukin-10: a key cytokine in depression?
@nl
prefLabel
Interleukin-10: a key cytokine in depression?
@en
Interleukin-10: a key cytokine in depression?
@nl
P2860
P50
P356
P1476
Interleukin-10: a key cytokine in depression?
@en
P2093
Margarida Correia-Neves
Nuno Sousa
P2860
P304
P356
10.1155/2009/187894
P577
2009-08-16T00:00:00Z